Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

BACKGROUND: There is strong evidence of under-reporting of harms in manuscripts on randomized controlled trials (RCTs) compared with the volume of raw data retrieved from these trials. Many guidelines have been developed to tackle this, but they have failed to address some important issues that woul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drugs Aging
Main Authors: Honvo, Germain, Bannuru, Raveendhara R., Bruyère, Olivier, Rannou, Francois, Herrero-Beaumont, Gabriel, Uebelhart, Daniel, Cooper, Cyrus, Arden, Nigel, Conaghan, Philip G., Reginster, Jean-Yves, Thomas, Thierry, McAlindon, Tim
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Leading Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509216/
https://ncbi.nlm.nih.gov/pubmed/31073927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40266-019-00667-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados